Skip to main content
Erschienen in: Skeletal Radiology 7/2015

01.07.2015 | Case Report

Giant cell tumor of soft tissue: a case report with emphasis on MR imaging

verfasst von: Moon Young Lee, Won-Hee Jee, Chan Kwon Jung, Ie Ryung Yoo, Yang-Guk Chung

Erschienen in: Skeletal Radiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Giant cell tumor of soft tissue is a rare neoplasm, histologically resembling giant cell tumor of bone. In this report, we describe a deep and solid giant cell tumor of soft tissue interpreted as a benign soft tissue tumor based on magnetic resonance (MR) findings with hypointense to intermediate signals on T2-weighted images and impeded diffusivity (water movement) on diffusion-weighted imaging (DWI), which could suggest a giant-cell-containing benign soft tissue tumor, despite the malignancy suggested by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a 35-year-old male. To our knowledge, this report introduces the first deep, solid giant cell tumor of soft tissue with MR features of a giant-cell-containing benign soft tissue tumor, despite the malignancy-mimicking findings on 18 F-FDG PET-CT.
Literatur
1.
Zurück zum Zitat Kransdorf MJ, Murphey MD. Imaging of soft tissue tumors. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2014. Kransdorf MJ, Murphey MD. Imaging of soft tissue tumors. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2014.
2.
Zurück zum Zitat An SB, Choi JA, Chung JH, Oh JH, Kang HS. Giant cell tumor of soft tissue: a case with atypical US and MRI findings. Korean J Radiol. 2008;9:462–5.CrossRefPubMedCentralPubMed An SB, Choi JA, Chung JH, Oh JH, Kang HS. Giant cell tumor of soft tissue: a case with atypical US and MRI findings. Korean J Radiol. 2008;9:462–5.CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Meana Moris AR, Garcia Gonzalez P, Fuente Martin E, Gonzalez Suarez C, Moro BL. Primary giant cell tumor of soft tissue: fluid-fluid levels at MRI (2010:3b). Eur Radiol. 2010;20:1539–43.CrossRefPubMed Meana Moris AR, Garcia Gonzalez P, Fuente Martin E, Gonzalez Suarez C, Moro BL. Primary giant cell tumor of soft tissue: fluid-fluid levels at MRI (2010:3b). Eur Radiol. 2010;20:1539–43.CrossRefPubMed
4.
Zurück zum Zitat Fletcher CDM, World Health O. International agency for research on C. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. Fletcher CDM, World Health O. International agency for research on C. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013.
5.
Zurück zum Zitat O’Connell JX, Wehrli BM, Nielsen GP, Rosenberg AE. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors. Am J Surg Pathol. 2000;24:386–95.CrossRefPubMed O’Connell JX, Wehrli BM, Nielsen GP, Rosenberg AE. Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors. Am J Surg Pathol. 2000;24:386–95.CrossRefPubMed
6.
Zurück zum Zitat Aoki J, Moriya K, Yamashita K, et al. Giant cell tumors of bone containing large amounts of hemosiderin: MR-pathologic correlation. J Comput Assist Tomogr. 1991;15:1024–7.CrossRefPubMed Aoki J, Moriya K, Yamashita K, et al. Giant cell tumors of bone containing large amounts of hemosiderin: MR-pathologic correlation. J Comput Assist Tomogr. 1991;15:1024–7.CrossRefPubMed
7.
Zurück zum Zitat Strauss LG, Dimitrakopoulou-Strauss A, Koczan D, et al. 18 F-FDG kinetics and gene expression in giant cell tumors. J Nucl Med. 2004;45:1528–35.PubMed Strauss LG, Dimitrakopoulou-Strauss A, Koczan D, et al. 18 F-FDG kinetics and gene expression in giant cell tumors. J Nucl Med. 2004;45:1528–35.PubMed
8.
Zurück zum Zitat Hoshi M, Takada J, Oebisu N, Hata K, Ieguchi M, Nakamura H. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT. Arch Orthop Trauma Surg. 2012;132:1561–8.CrossRefPubMed Hoshi M, Takada J, Oebisu N, Hata K, Ieguchi M, Nakamura H. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT. Arch Orthop Trauma Surg. 2012;132:1561–8.CrossRefPubMed
9.
Zurück zum Zitat Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol. 2003;32:133–8.CrossRefPubMed Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol. 2003;32:133–8.CrossRefPubMed
10.
Zurück zum Zitat Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics. 2001;21:1283–309.CrossRefPubMed Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics. 2001;21:1283–309.CrossRefPubMed
11.
Zurück zum Zitat Kwon JW, Chung HW, Cho EY, et al. MRI findings of giant cell tumors of the spine. AJR Am J Roentgenol. 2007;189:246–50.CrossRefPubMed Kwon JW, Chung HW, Cho EY, et al. MRI findings of giant cell tumors of the spine. AJR Am J Roentgenol. 2007;189:246–50.CrossRefPubMed
12.
Zurück zum Zitat Nagata S, Nishimura H, Uchida M, et al. Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med. 2008;26:287–95.CrossRefPubMed Nagata S, Nishimura H, Uchida M, et al. Diffusion-weighted imaging of soft tissue tumors: usefulness of the apparent diffusion coefficient for differential diagnosis. Radiat Med. 2008;26:287–95.CrossRefPubMed
13.
Zurück zum Zitat Lee SY, Jee WH, Jung JY, et al. Differentiation of malignant from benign soft tissue tumors: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T. Eur Radiol. 2015 in press. Lee SY, Jee WH, Jung JY, et al. Differentiation of malignant from benign soft tissue tumors: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T. Eur Radiol. 2015 in press.
14.
Zurück zum Zitat Oliveira AM, Dei Tos AP, Fletcher CD, Nascimento AG. Primary giant cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol. 2000;24:248–56.CrossRefPubMed Oliveira AM, Dei Tos AP, Fletcher CD, Nascimento AG. Primary giant cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol. 2000;24:248–56.CrossRefPubMed
15.
Zurück zum Zitat Dodd LG, Major N, Brigman B. Malignant giant cell tumor of soft parts. Skeletal Radiol. 2004;33:295–9.CrossRefPubMed Dodd LG, Major N, Brigman B. Malignant giant cell tumor of soft parts. Skeletal Radiol. 2004;33:295–9.CrossRefPubMed
Metadaten
Titel
Giant cell tumor of soft tissue: a case report with emphasis on MR imaging
verfasst von
Moon Young Lee
Won-Hee Jee
Chan Kwon Jung
Ie Ryung Yoo
Yang-Guk Chung
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 7/2015
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-015-2140-6

Weitere Artikel der Ausgabe 7/2015

Skeletal Radiology 7/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.